Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Peptides for Immunoenzymatic Assays Immobilized on Microplates

By LabMedica International staff writers
Posted on 28 Aug 2012
Synthetic peptides are widely used in indirect enzyme-linked immunosorbent assays (ELISA) to detect and characterize specific antibodies in clinical samples. More...


A simple, fast, and inexpensive protocol has been described that shows how immobilized synthetic peptides can be bound to plastic surfaces for standard ELISA, which could be used as an alternative to the common technique of conjugating peptide antigens to carrier proteins.

Scientists at the University of Sassari (Italy) devised the technique, which is based on the use of maleimide-activated bovine serum albumin or keyhole limpet hemocyanin as a protein anchor adsorbed on the polystyrene surface of the microtiter plate. Following adsorption of the carrier protein, sulfhydryl-containing peptides are cross-linked with an in-well reaction, allowing their correct orientation and availability to antibody binding, avoiding the time consuming steps needed to purify the hapten–carrier complexes.

Conventional in-solution maleimide-mediated coupling reaction (ISC) was performed by using the Imject Maleimide Activated Immunogen Conjugation kit (Pierce; Rockford, IL, USA). Nine synthetic peptides (Nurex; Sassari, Italy) with length ranging from 10 to 15 amino acids were designed to display different hydrophobic/hydrophilic characteristics and to carry either an N or C terminal cysteine, to allow cross-linking with maleimide-activated carrier proteins. The immunoreactivity of peptides was tested by using both monoclonal and polyclonal antibodies in standard ELISA assays, and compared with established coating methods.

The efficiency of direct cross-linking method (DCLM) was tested with four different peptides and subsequent standard indirect ELISA with polyclonal antibodies was performed. All the sera specifically recognized the corresponding specific antigens when directly cross-linked onto the multiwell plate. Results in terms of signal strength were comparable to that obtained with ELISAs performed by using plates coated with ISC conjugates.

The authors concluded that DCLM proved to be simple, reproducible, cost-effective, and suitable with peptides of different lengths and hydrophobic/hydrophilic characteristics. The DCLM can be considered a straightforward, faster, and much more convenient alternative to standard coupling protocols, allowing saving time and cut costs in ELISA applications. When considering its time- and cost-effectiveness, DCLM may prove to be applicable also to automated systems for high-throughput peptide screenings. The study was published in the August 2012 edition of the Journal of Immunological Methods.

Related Links:

The University of Sassari
Pierce
Nurex



Platinum Member
Xylazine Immunoassay Test
Xylazine ELISA
Verification Panels for Assay Development & QC
Seroconversion Panels
Anti-Cyclic Citrullinated Peptide Test
GPP-100 Anti-CCP Kit
Gold Member
NEW PRODUCT : SILICONE WASHING MACHINE TRAY COVER WITH VICOLAB SILICONE NET VICOLAB®
REGISTRED 682.9
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Clinical Chemistry

view channel
Image: QIP-MS could predict and detect myeloma relapse earlier compared to currently used techniques (Photo courtesy of Adobe Stock)

Mass Spectrometry-Based Monitoring Technique to Predict and Identify Early Myeloma Relapse

Myeloma, a type of cancer that affects the bone marrow, is currently incurable, though many patients can live for over 10 years after diagnosis. However, around 1 in 5 individuals with myeloma have a high-risk... Read more

Technology

view channel
Image: Ziyang Wang and Shengxi Huang have developed a tool that enables precise insights into viral proteins and brain disease markers (Photo courtesy of Jeff Fitlow/Rice University)

Light Signature Algorithm to Enable Faster and More Precise Medical Diagnoses

Every material or molecule interacts with light in a unique way, creating a distinct pattern, much like a fingerprint. Optical spectroscopy, which involves shining a laser on a material and observing how... Read more

Industry

view channel
Image: The collaboration aims to leverage Oxford Nanopore\'s sequencing platform and Cepheid\'s GeneXpert system to advance the field of sequencing for infectious diseases (Photo courtesy of Cepheid)

Cepheid and Oxford Nanopore Technologies Partner on Advancing Automated Sequencing-Based Solutions

Cepheid (Sunnyvale, CA, USA), a leading molecular diagnostics company, and Oxford Nanopore Technologies (Oxford, UK), the company behind a new generation of sequencing-based molecular analysis technologies,... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.